Featured News

Does living with celiac disease impact your daily life? We need your help to advance celiac disease research and test an investigational medication.  

Is celiac disease holding you back? If so, consider joining the FB102-301 study for people who have celiac disease who are currently on a gluten-free diet. The phase 2 FB102-301 study is researching a potential new…

And Why the Celiac Disease Foundation’s Global Leadership Helped Make This Moment Possible Today, the U.S. Food and Drug Administration (FDA) announced a major step toward improving how gluten and…

Clarifying Public Act 104-0090 (SB1288) Last week the Celiac Disease Foundation held a seminar in partnership with the Illinois Department of Public Health (IDPH) to provide education on celiac disease,…

At the Harvard AI Symposium this fall, Dr. Nan Du and an interdisciplinary research team from Boston Children’s Hospital unveiled MedTutor AI, an innovative artificial intelligence platform designed to improve…

The Celiac Disease Foundation and the Society for the Study of Celiac Disease (SSCD) are joining forces to accelerate progress in celiac disease research, clinical care, and advocacy. The SSCD — the…

Is celiac disease having a significant impact on your daily life? You may be eligible for a clinical study. The ASPIRION study is a phase 2 study looking into a new, investigational study drug (amlitelimab) for patients with celiac disease.

New Phase 2 Clinical Trial: TEV-CeD2 Study

A new international study published in the journal Gastroenterology sheds light on the extensive economic burden of celiac disease. In addition to the cost of gluten-free  foods, the authors address…

On May 20 the Disease Foundation hosted its third annual award reception at Digestive Disease Week in Washington, D.C. From prestigious global research prizes to inaugural student and policy leadership awards, the event spotlighted the extraordinary contributions of individuals dedicated to improving the lives of those affected by celiac disease.